Crossmark

Interleukin-31 and soluble CD40L: new candidate serum biomarkers that predict therapeutic response in multiple sclerosis

Crossref DOI link: https://doi.org/10.1007/s10072-022-06276-5

Published Online: 2022-07-18

Published Print: 2022-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pastor Bandeira, Isabelle https://orcid.org/0000-0002-6463-5414
de Almeida Franzoi, André Eduardo https://orcid.org/0000-0001-9616-0698
Murillo Wollmann, Giulia https://orcid.org/0000-0002-5515-1362
de Medeiros Junior, Washigton Luiz Gomes https://orcid.org/0000-0002-8446-4165
Nogueira Brandão, Wesley https://orcid.org/0000-0001-9306-3251
Schatzmann Peron, Jean Pierre https://orcid.org/0000-0003-1638-8866
Becker, Jefferson https://orcid.org/0000-0002-9981-3620
Nascimento, Osvaldo José Moreira https://orcid.org/0000-0003-3516-485X
Magno Gonçalves, Marcus Vinícius https://orcid.org/0000-0002-9127-7886
License Information

Text and Data Mining valid from 2022-07-18

Version of Record valid from 2022-07-18
More Information

Article History

Received: 5 April 2022

Accepted: 11 July 2022

First Online: 18 July 2022

Declarations

:

: The authors declare no competing interests.

: None.